Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W2884044665', 'doi': 'https://doi.org/10.1016/j.ymgme.2018.07.013', 'title': 'Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS', 'display_name': 'Evaluation of cerebrospinal fluid heparan sulfate as a biomarker of neuropathology in a murine model of mucopolysaccharidosis type II using high-sensitivity LC/MS/MS', 'publication_year': 2018, 'publication_date': '2018-07-23', 'ids': {'openalex': 'https://openalex.org/W2884044665', 'doi': 'https://doi.org/10.1016/j.ymgme.2018.07.013', 'mag': '2884044665', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/30064964'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/j.ymgme.2018.07.013', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S42433034', 'display_name': 'Molecular Genetics and Metabolism', 'issn_l': '1096-7192', 'issn': ['1096-7192', '1096-7206'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': True, 'oa_status': 'hybrid', 'oa_url': 'https://doi.org/10.1016/j.ymgme.2018.07.013', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5056008744', 'display_name': 'Noboru Tanaka', 'orcid': 'https://orcid.org/0000-0003-4563-9089'}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': True, 'raw_author_name': 'Noboru Tanaka', 'raw_affiliation_strings': ['Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan'], 'affiliations': [{'raw_affiliation_string': 'Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5001359076', 'display_name': 'Sachiho Kida', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Sachiho Kida', 'raw_affiliation_strings': ['Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan'], 'affiliations': [{'raw_affiliation_string': 'Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5077538199', 'display_name': 'Masafumi Kinoshita', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Masafumi Kinoshita', 'raw_affiliation_strings': ['Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan'], 'affiliations': [{'raw_affiliation_string': 'Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5024703723', 'display_name': 'Hideto Morimoto', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Hideto Morimoto', 'raw_affiliation_strings': ['Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan'], 'affiliations': [{'raw_affiliation_string': 'Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5023698512', 'display_name': 'Tadao Shibasaki', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Tadao Shibasaki', 'raw_affiliation_strings': ['Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan'], 'affiliations': [{'raw_affiliation_string': 'Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101135801', 'display_name': 'Katsuhiko Tachibana', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Katsuhiko Tachibana', 'raw_affiliation_strings': ['Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan'], 'affiliations': [{'raw_affiliation_string': 'Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5035424097', 'display_name': 'Ryûji Yamamoto', 'orcid': 'https://orcid.org/0009-0002-9215-544X'}, 'institutions': [{'id': 'https://openalex.org/I4210095800', 'display_name': 'JCR Pharmaceuticals (Japan)', 'ror': 'https://ror.org/00vqs2b71', 'country_code': 'JP', 'type': 'company', 'lineage': ['https://openalex.org/I4210095800']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Ryuji Yamamoto', 'raw_affiliation_strings': ['Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan'], 'affiliations': [{'raw_affiliation_string': 'Research Division, JCR Pharmaceuticals, 2-2-9 Murotani, Nishi-ku, Kobe 651-2241, Japan', 'institution_ids': ['https://openalex.org/I4210095800']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': ['https://openalex.org/A5056008744'], 'corresponding_institution_ids': ['https://openalex.org/I4210095800'], 'apc_list': {'value': 3570, 'currency': 'USD', 'value_usd': 3570, 'provenance': 'doaj'}, 'apc_paid': {'value': 3570, 'currency': 'USD', 'value_usd': 3570, 'provenance': 'doaj'}, 'fwci': 3.223, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 37, 'citation_normalized_percentile': {'value': 0.999954, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 95, 'max': 96}, 'biblio': {'volume': '125', 'issue': '1-2', 'first_page': '53', 'last_page': '58'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10945', 'display_name': 'Lysosomal Storage Disorders Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10945', 'display_name': 'Lysosomal Storage Disorders Research', 'score': 1.0, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12604', 'display_name': 'Glycogen Storage Diseases and Myoclonus', 'score': 0.9886, 'subfield': {'id': 'https://openalex.org/subfields/2745', 'display_name': 'Rheumatology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10890', 'display_name': 'Trypanosoma species research and implications', 'score': 0.9855, 'subfield': {'id': 'https://openalex.org/subfields/2713', 'display_name': 'Epidemiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/mucopolysaccharidosis-type-ii', 'display_name': 'Mucopolysaccharidosis type II', 'score': 0.8759943}, {'id': 'https://openalex.org/keywords/hunter-syndrome', 'display_name': 'Hunter syndrome', 'score': 0.68036866}, {'id': 'https://openalex.org/keywords/mucopolysaccharidosis-i', 'display_name': 'Mucopolysaccharidosis I', 'score': 0.52540594}, {'id': 'https://openalex.org/keywords/mucopolysaccharidosis', 'display_name': 'Mucopolysaccharidosis', 'score': 0.47482404}, {'id': 'https://openalex.org/keywords/lysosomal-storage-disease', 'display_name': 'Lysosomal storage disease', 'score': 0.44128877}], 'concepts': [{'id': 'https://openalex.org/C2910638406', 'wikidata': 'https://www.wikidata.org/wiki/Q1529983', 'display_name': 'Mucopolysaccharidosis type II', 'level': 4, 'score': 0.8759943}, {'id': 'https://openalex.org/C2778041096', 'wikidata': 'https://www.wikidata.org/wiki/Q424668', 'display_name': 'Heparan sulfate', 'level': 3, 'score': 0.76681685}, {'id': 'https://openalex.org/C2779651940', 'wikidata': 'https://www.wikidata.org/wiki/Q54196', 'display_name': 'Cerebrospinal fluid', 'level': 2, 'score': 0.73173136}, {'id': 'https://openalex.org/C2776225084', 'wikidata': 'https://www.wikidata.org/wiki/Q1529983', 'display_name': 'Hunter syndrome', 'level': 2, 'score': 0.68036866}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.6015092}, {'id': 'https://openalex.org/C2910727661', 'wikidata': 'https://www.wikidata.org/wiki/Q25379699', 'display_name': 'Mucopolysaccharidosis I', 'level': 4, 'score': 0.52540594}, {'id': 'https://openalex.org/C2779416428', 'wikidata': 'https://www.wikidata.org/wiki/Q1479681', 'display_name': 'Mucopolysaccharidosis', 'level': 2, 'score': 0.47482404}, {'id': 'https://openalex.org/C40767141', 'wikidata': 'https://www.wikidata.org/wiki/Q285697', 'display_name': 'Recombinant DNA', 'level': 3, 'score': 0.45738098}, {'id': 'https://openalex.org/C153074725', 'wikidata': 'https://www.wikidata.org/wiki/Q407553', 'display_name': 'Glycosaminoglycan', 'level': 2, 'score': 0.45140445}, {'id': 'https://openalex.org/C2781197716', 'wikidata': 'https://www.wikidata.org/wiki/Q864574', 'display_name': 'Biomarker', 'level': 2, 'score': 0.4483312}, {'id': 'https://openalex.org/C2778264360', 'wikidata': 'https://www.wikidata.org/wiki/Q675010', 'display_name': 'Lysosomal storage disease', 'level': 3, 'score': 0.44128877}, {'id': 'https://openalex.org/C2779969927', 'wikidata': 'https://www.wikidata.org/wiki/Q916766', 'display_name': 'Enzyme replacement therapy', 'level': 3, 'score': 0.4140469}, {'id': 'https://openalex.org/C181199279', 'wikidata': 'https://www.wikidata.org/wiki/Q8047', 'display_name': 'Enzyme', 'level': 2, 'score': 0.29797065}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.2721067}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.22518793}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.22512668}, {'id': 'https://openalex.org/C2779134260', 'wikidata': 'https://www.wikidata.org/wiki/Q12136', 'display_name': 'Disease', 'level': 2, 'score': 0.07903147}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D015415', 'descriptor_name': 'Biomarkers', 'qualifier_ui': 'Q000134', 'qualifier_name': 'cerebrospinal fluid', 'is_major_topic': True}, {'descriptor_ui': 'D006497', 'descriptor_name': 'Heparitin Sulfate', 'qualifier_ui': 'Q000134', 'qualifier_name': 'cerebrospinal fluid', 'is_major_topic': True}, {'descriptor_ui': 'D016532', 'descriptor_name': 'Mucopolysaccharidosis II', 'qualifier_ui': 'Q000134', 'qualifier_name': 'cerebrospinal fluid', 'is_major_topic': True}, {'descriptor_ui': 'D009422', 'descriptor_name': 'Nervous System Diseases', 'qualifier_ui': 'Q000134', 'qualifier_name': 'cerebrospinal fluid', 'is_major_topic': True}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015415', 'descriptor_name': 'Biomarkers', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001812', 'descriptor_name': 'Blood-Brain Barrier', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D001812', 'descriptor_name': 'Blood-Brain Barrier', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001921', 'descriptor_name': 'Brain', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D001921', 'descriptor_name': 'Brain', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001921', 'descriptor_name': 'Brain', 'qualifier_ui': 'Q000378', 'qualifier_name': 'metabolism', 'is_major_topic': False}, {'descriptor_ui': 'D001921', 'descriptor_name': 'Brain', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D002853', 'descriptor_name': 'Chromatography, Liquid', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D003871', 'descriptor_name': 'Dermatan Sulfate', 'qualifier_ui': 'Q000134', 'qualifier_name': 'cerebrospinal fluid', 'is_major_topic': False}, {'descriptor_ui': 'D003871', 'descriptor_name': 'Dermatan Sulfate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004195', 'descriptor_name': 'Disease Models, Animal', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006497', 'descriptor_name': 'Heparitin Sulfate', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D006497', 'descriptor_name': 'Heparitin Sulfate', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D007066', 'descriptor_name': 'Iduronate Sulfatase', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D007066', 'descriptor_name': 'Iduronate Sulfatase', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D051379', 'descriptor_name': 'Mice', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018345', 'descriptor_name': 'Mice, Knockout', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016532', 'descriptor_name': 'Mucopolysaccharidosis II', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': False}, {'descriptor_ui': 'D016532', 'descriptor_name': 'Mucopolysaccharidosis II', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D016532', 'descriptor_name': 'Mucopolysaccharidosis II', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D016532', 'descriptor_name': 'Mucopolysaccharidosis II', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D009422', 'descriptor_name': 'Nervous System Diseases', 'qualifier_ui': 'Q000473', 'qualifier_name': 'pathology', 'is_major_topic': False}, {'descriptor_ui': 'D009422', 'descriptor_name': 'Nervous System Diseases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011990', 'descriptor_name': 'Receptors, Transferrin', 'qualifier_ui': 'Q000235', 'qualifier_name': 'genetics', 'is_major_topic': False}, {'descriptor_ui': 'D011990', 'descriptor_name': 'Receptors, Transferrin', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D053719', 'descriptor_name': 'Tandem Mass Spectrometry', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/j.ymgme.2018.07.013', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S42433034', 'display_name': 'Molecular Genetics and Metabolism', 'issn_l': '1096-7192', 'issn': ['1096-7192', '1096-7206'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/30064964', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1016/j.ymgme.2018.07.013', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S42433034', 'display_name': 'Molecular Genetics and Metabolism', 'issn_l': '1096-7192', 'issn': ['1096-7192', '1096-7206'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320990', 'host_organization_name': 'Elsevier BV', 'host_organization_lineage': ['https://openalex.org/P4310320990'], 'host_organization_lineage_names': ['Elsevier BV'], 'type': 'journal'}, 'license': 'cc-by-nc-nd', 'license_id': 'https://openalex.org/licenses/cc-by-nc-nd', 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'score': 0.75, 'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3'}], 'grants': [{'funder': 'https://openalex.org/F4320310076', 'funder_display_name': 'National Center for Child Health and Development', 'award_id': None}], 'datasets': [], 'versions': [], 'referenced_works_count': 27, 'referenced_works': ['https://openalex.org/W1481319330', 'https://openalex.org/W1967749721', 'https://openalex.org/W1971770267', 'https://openalex.org/W1978346734', 'https://openalex.org/W2001101692', 'https://openalex.org/W2004893995', 'https://openalex.org/W2010188647', 'https://openalex.org/W2012973972', 'https://openalex.org/W2034981978', 'https://openalex.org/W2036630447', 'https://openalex.org/W2043490832', 'https://openalex.org/W2088174647', 'https://openalex.org/W2092327321', 'https://openalex.org/W2092848229', 'https://openalex.org/W2102067858', 'https://openalex.org/W2112373900', 'https://openalex.org/W2135874839', 'https://openalex.org/W2137730372', 'https://openalex.org/W2138335140', 'https://openalex.org/W2149155376', 'https://openalex.org/W2181441760', 'https://openalex.org/W2307511944', 'https://openalex.org/W2526629344', 'https://openalex.org/W2745716847', 'https://openalex.org/W2747229802', 'https://openalex.org/W2793073482', 'https://openalex.org/W34270362'], 'related_works': ['https://openalex.org/W820401292', 'https://openalex.org/W4312042812', 'https://openalex.org/W3128228216', 'https://openalex.org/W3096456408', 'https://openalex.org/W247452021', 'https://openalex.org/W2426578892', 'https://openalex.org/W2276056773', 'https://openalex.org/W2159157292', 'https://openalex.org/W2125094583', 'https://openalex.org/W2015597043'], 'abstract_inverted_index': {'Mucopolysaccharidosis': [0], 'type': [1], 'II': [2, 4, 51], '(MPS': [3], 'or': [5], 'Hunter': [6], 'syndrome)': [7], 'is': [8, 52], 'a': [9, 15, 78, 155, 241], 'lysosomal': [10], 'storage': [11], 'disorder': [12], 'caused': [13], 'by': [14, 166], 'deficiency': [16], 'of': [17, 60, 95, 108, 117, 124, 145, 206, 222, 254], 'iduronate-2-sulfatase': [18], '(IDS),': [19], 'an': [20, 105, 143], 'enzyme': [21, 54], 'that': [22, 132, 192, 235], 'catabolizes': [23], 'glycosaminoglycans': [24], '(GAGs)': [25], 'including': [26], 'heparan': [27], 'sulfate': [28, 32], '(HS)': [29], 'and': [30, 40, 84, 100, 161, 170, 183, 190, 227, 250], 'dermatan': [31], '(DS).': [33], 'GAG': [34, 90, 119, 133, 147, 248], 'accumulation': [35, 91, 120, 249], 'leads': [36], 'to': [37, 63, 88, 180], 'severe': [38], 'neurological': [39, 73], 'somatic': [41], 'impairments.': [42], 'At': [43], 'present,': [44], 'the': [45, 58, 65, 93, 115, 122, 136, 199, 225, 246, 251], 'most': [46], 'common': [47], 'treatment': [48, 217], 'for': [49, 72, 158, 244], 'MPS': [50, 109, 128, 259], 'intravenous': [53, 112, 216], 'replacement': [55], 'therapy;': [56], 'however,': [57], 'inability': [59], 'recombinant': [61], 'IDS': [62, 80], 'cross': [64], 'blood-brain': [66], 'barrier': [67], '(BBB)': [68], 'restricts': [69], 'therapeutic': [70, 252], 'efficacy': [71, 253], 'manifestations.': [74], 'We': [75, 176], 'recently': [76], 'developed': [77], 'BBB-penetrating': [79], 'fusion': [81], 'protein,': [82], 'JR-141,': [83], 'demonstrated': [85], 'its': [86], 'ability': [87], 'reduce': [89], 'in': [92, 121, 135, 163, 185, 198, 208, 213, 224, 229, 256], 'brain': [94, 146, 228, 247], 'human': [96, 125], 'transferrin': [97], 'receptor': [98], 'knock-in': [99], 'Ids': [101], 'knock-out': [102], 'mice': [103, 189], '(TFRC-KI/Ids-KO),': [104], 'animal': [106], 'model': [107], 'II,': [110, 129], 'following': [111], 'administration.': [113], 'Given': [114], 'impossibility': [116], 'measuring': [118], 'brains': [123], 'patients': [126, 257], 'with': [127, 211, 218, 258], 'we': [130, 153], 'hypothesized': [131], 'content': [134, 238], 'cerebrospinal': [137], 'fluid': [138], '(CSF)': [139], 'might': [140], 'serve': [141], 'as': [142], 'indicator': [144], 'burden.': [148], 'To': [149], 'test': [150], 'this': [151, 178], 'hypothesis,': [152], 'optimized': [154], 'high-sensitivity': [156], 'method': [157, 179], 'quantifying': [159], 'HS': [160, 182, 193, 207, 223, 237], 'DS': [162, 184, 196], 'low-volume': [164], 'samples': [165, 186], 'combining': [167], 'acidic': [168], 'methanolysis': [169], 'liquid': [171], 'chromatography-tandem': [172], 'mass': [173], 'spectrometry': [174], '(LC/MS/MS).': [175], 'employed': [177], 'quantify': [181], 'from': [187], 'TFRC-KI/Ids-KO': [188, 230], 'revealed': [191], 'but': [194], 'not': [195], 'accumulated': [197], 'central': [200], 'nerve': [201], 'system': [202], '(CNS).': [203], 'Moreover,': [204], 'concentrations': [205], 'CSF': [209, 226, 236], 'correlated': [210], 'those': [212], 'brain.': [214], 'Finally,': [215], 'JR-141': [219], 'reduced': [220], 'levels': [221], 'mice.': [231], 'These': [232], 'results': [233], 'suggest': [234], 'may': [239], 'be': [240], 'useful': [242], 'biomarker': [243], 'evaluating': [245], 'drugs': [255], 'II.': [260]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2884044665', 'counts_by_year': [{'year': 2024, 'cited_by_count': 3}, {'year': 2023, 'cited_by_count': 5}, {'year': 2022, 'cited_by_count': 8}, {'year': 2021, 'cited_by_count': 10}, {'year': 2020, 'cited_by_count': 5}, {'year': 2019, 'cited_by_count': 3}, {'year': 2018, 'cited_by_count': 3}], 'updated_date': '2024-12-17T02:32:37.805947', 'created_date': '2018-08-03'}